Orange Book product · Generic (ANDA)
CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
At a glance
Jul 21, 2020
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 21, 2020
6 yr ago
Today
Pharmaceutical detail
Active ingredient
CEFEPIME HYDROCHLORIDE
Strength
EQ 1GM BASE/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 212721
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFEPIME HYDROCHLORIDE
- 2010CEFEPIME AND DEXTROSE IN DUPLEX CONTAINERBrand (NDA)
NDA 050821 · B BRAUN
- 2008CEFEPIME IN PLASTIC CONTAINERBrand (NDA)
NDA 050817 · BAXTER HLTHCARE
- 1996MAXIPIMEBrand (NDA)
NDA 050679 · HOSPIRA INC
- 2024CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 214402 · HIKMA
- 2018CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINERGeneric (ANDA)
ANDA 209408 · SAMSON MEDCL
- 2017CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 091048 · SAGENT PHARMS INC
- 2016CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 203704 · QILU ANTIBIOTICS
- 2012CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 202268 · HOSPIRA INC
- 2010CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 090291 · CHARTWELL RX
- 2008CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 065441 · ACS DOBFAR
- 2007CEFEPIME HYDROCHLORIDEGeneric (ANDA)
ANDA 065369 · HOSPIRA INC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
